Single cell immunoprofile of synovial fluid in rheumatoid arthritis with TNF/JAK inhibitor treatment
Numerous patients with rheumatoid arthritis (RA) manifest severe syndromes, including elevated synovial fluid volumes (SF) with abundant immune cells, which can be controlled by TNF/JAK inhibitors. Here, we apply single-cell RNA sequencing (scRNA-seq) and subsequent validations in SF from RA patients. These analyses of synovial tissue show reduced density of SF-derived pathogenic cells (e.g., SPP1<sup>+</sup> macrophages and CXCL13<sup>+</sup>CD4<sup>+</sup> T cells), altered gene expression (e.g., SPP1 and STAT1), molecular pathway changes (e.g., JAK/STAT), and cell-cell communications in drug-specific manners in samples from patients pre-/post-treated with adalimumab/tofacitinib. Particularly, SPP1<sup>+</sup> macrophages exhibit pronounced communication with CXCL13<sup>+</sup>CD4<sup>+</sup> T cells, which are abolished after treatment and correlate with treatment efficacy. These pathogenic cell types alone or in combination can augment inflammation of fibroblast-like synoviocytes in vitro, while conditional Spp1 knocking-out reduces RA-related cytokine expression in collagen-induced arthritis mice models. Our study shows the functional role of SF-derived pathogenic cells in progression and drug-specific treatment outcomes in RA.
Authors
- Chenjia He (ORCID: https://orcid.org/0009-0007-6199-8109)
- Yun Qin (ORCID: https://orcid.org/0009-0004-0778-4263)
- Maoxiang Qian (ORCID: https://orcid.org/0000-0003-2889-546X)
- Qibing Xie (ORCID: https://orcid.org/0000-0002-6727-1839)
- Li‐Bin Huang (ORCID: https://orcid.org/0000-0002-2614-5764)
- Xuyang Xia (ORCID: https://orcid.org/0000-0003-4230-7265)
- Yang Shu (ORCID: https://orcid.org/0000-0002-8304-1531)
- Hai‐Ning Chen (ORCID: https://orcid.org/0000-0003-0104-8498)
- Zhinan Xue
- Yupeng Huang (ORCID: https://orcid.org/0000-0002-9978-2393)
- Han Luo (ORCID: https://orcid.org/0000-0002-9674-0139)
- Geping Yin (ORCID: https://orcid.org/0000-0002-8197-9585)
- Yunying Shi (ORCID: https://orcid.org/0000-0002-4544-5439)
- Feng Zhang (ORCID: https://orcid.org/0000-0002-6751-0377)
- Wei Zhang (ORCID: https://orcid.org/0000-0003-3704-6013)
- Lanlan Wang (ORCID: https://orcid.org/0000-0002-1640-7839)
- Heng Xu (ORCID: https://orcid.org/0000-0002-7748-2621)
- Weihan Zhang (ORCID: https://orcid.org/0000-0002-9498-8245)
- Bei Cai (ORCID: https://orcid.org/0000-0001-9872-6747)
- Yangjuan Bai
- Zhixiang Ren
- Yuelan Wang
Institutions
- Central South University (CN)
- Sichuan University (CN)
- Fudan University (CN)
- Wenzhou Medical University (CN)
- West China Medical Center of Sichuan University (CN)
- Quzhou City People's Hospital (CN)
- West China Hospital of Sichuan University (CN)
- Children's Hospital of Fudan University (CN)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1038/s41467-025-57361-0
- Citations
- 28
- Primary Topic
- T-cell and B-cell Immunology
- Type
- article
- Field-Weighted Citation Impact
- 22.33
Funders
- National Natural Science Foundation of China
- National Key Research and Development Program of China